Radlink, Inc. is a medical technology innovator that has carved a niche for itself with its orthopedic surgical navigation software and AI capabilities, as highlighted by their slogan "AIfortheOR." Founded in 2000 and headquartered in the United States, Radlink focuses on developing cutting-edge medical imaging technology, orthopedic surgical guidance systems, and AI-enabled software solutions. They have gained prominence through an extensive portfolio of intelligent image-based products for orthopedics, radiology, and private physician offices.
One of Radlink's standout products is the Surgeon’s Checklist® Software, a non-invasive surgical guidance system that offers preoperative case planning, intraoperative AI imaging analysis, and verification of component positioning in various medical procedures. This technology provides real-time feedback and patient-specific measurements, guiding surgeons to make more informed decisions intra-operatively, ultimately leading to improved patient outcomes. Radlink takes pride in the fact that its patented AI-enabled technology is non-invasive and seamlessly integrates into a surgeon's existing workflow. Moreover, it has been validated in clinical studies to enhance accuracy, precision, and efficiency during surgery.
Emphasizing compliance and quality, all Radlink products are FDA approved, CE Marked, and ISO 13485 certified. With a strong focus on technological innovation and a track record of success, Radlink, Inc. presents an intriguing opportunity for potential investors in the health care and medical devices industries.
There is no investment information
No recent news or press coverage available for Radlink, Inc..